E-GEOD-42296 - Distinct, non-overlapping gene panels of peripheral blood gene expression predict response to infliximab therapy in rheumatoid arthritis and Crohn's disease

Status
Released on 25 June 2013, last updated on 1 July 2013
Organism
Homo sapiens
Samples (78)
Array (1)
Protocols (6)
Description
We used microarrays to identify markers predicting responder status in infliximab treatment in 19 rheumatoid arthritis and 20 Crohn's disease patients at week 0 and week 2 of treatment. Peripheral blood samples were obtained at week 0 and week 2 of inxliximab treatment and global gene expression profiling identified markers of responder status.
Experiment type
transcription profiling by array 
Contacts
Andrea Vancsa, Attila Horvath, Bertalan Mesko, Gabor Zahuczky, Janos Podani, Karoly Palatka, Laszlo Nagy, Laszlo Steiner, Szilard Poliska, Zoltan Szekanecz, Zsolt Hollo
MIAME
PlatformsProtocolsVariablesProcessedRaw
Files
Investigation descriptionE-GEOD-42296.idf.txt
Sample and data relationshipE-GEOD-42296.sdrf.txt
Raw data (2)E-GEOD-42296.raw.1.zip, E-GEOD-42296.raw.2.zip
Processed data (1)E-GEOD-42296.processed.1.zip
Array designA-AFFY-141.adf.txt
Links